Leap Therapeutics Inc (LPTX NASDAQ) stock market data APIs
$0.6261
0.01(1.6%)
as of October 15, 2025
Try our APIs with
free plan!
Leap Therapeutics Inc Financial Data Overview
Price chart is built with
Anychart
Leap Therapeutics, Inc., a biopharmaceutical company, acquires and develops antibody therapies for the treatment of cancer. Its lead clinical stage drug candidate includes DKN-01, a monoclonal antibody that inhibits Dickkopf-related protein 1, which is in various ongoing clinical trials for treating esophagogastric and gynecologic cancers, and colorectal cancer. The company also develops FL-501, a monoclonal antibody that inhibits GDF-15 protein that is in preclinical trial. It has an option and license agreement with Adimab, LLC and BeiGene, Ltd. to develop and commercialize DKN-01 in Asia (excluding Japan), Australia, and New Zealand. The company was formerly known as HealthCare Pharmaceuticals, Inc. and changed its name to Leap Therapeutics, Inc. in November 2015. Leap Therapeutics, Inc. was incorporated in 2011 and is based in Cambridge, Massachusetts.
Prev. Close
0.6261
Open
0.6319
High
0.6635
Low
0.6162
52 wk Range
0.2223-4.79
Market Cap
35 175 K
Shares Outstanding
56 652 K
Revenue
375 K
EPS
-0.4
Beta
-0.057
* We provide hundreds of fields of fundamental data, including EBITDA, P/E ratio, PEG ratio, trailing P/E, shareholders, insider transactions, technical metrics, dividends, splits, earnings, and more. Check out our Fundamental Data API.
ETFs with Leap Therapeutics Inc (top by weight)
Ticker
100-day Price Change
Weight
* We provide detailed information about ETF constituents through our Fundamentals API for ETFs. Read the documentation to learn more.
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
Get Leap Therapeutics Inc data using free add-ons & libraries
Get Leap Therapeutics Inc Fundamental Data
Leap Therapeutics Inc Fundamental data includes:
- Net Revenue: 375 K
- EBITDA: -62 691 500
- Earnings Per Share:
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
$
59.99
/mo.
End-of-day & Earnings data
What’s included:
- Latest Release: 2025-08-14
- EPS/Forecast: -0.42
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Leap Therapeutics Inc News
New
Leap Therapeutics Shares Jump on $59M Winklevoss-Led Crypto Deal
Shares of Leap Therapeutics (LPTX) climbed 25% after the microcap cancer drug developer announced a $58.9 million private investment led by Winklevoss Capital to kickstart a crypto treasury strategy. ...
Leap Therapeutics secures $58.9M PIPE to launch digital asset strategy; shares up 29%
* Leap Therapeutics (NASDAQ:LPTX [https://seekingalpha.com/symbol/LPTX]) announced a $58.9M PIPE financing led by Winklevoss Capital to support a new digital asset treasury strategy. * The offerin...
Global Ship Lease's Series B Preferred Shares Cross 8% Yield Mark
In trading on Wednesday, shares of Global Ship Lease, Inc.'s 8.75% Series B Cumulative Redeemable Perpetual Preferred Shares (Symbol: GSL.PRB) were yielding above the 8% mark based on its quarterly di...
Purple Biotech Appoints Shai Lankry as Chief Financial Officer
U.S.-based Lankry brings over 20 years of financial leadership in biotech and healthcare with a proven track record of driving strategic growth, operational excellence, and capital market execution, i...
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
- Price stability: Locked-in rates for subscribed users, never changing
All-In-One
$99.99/mo.
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.
